Multiple myeloma (MM) is a malignant proliferation of a single clone of plasma cells. These malignant cells produce monoclonal protein (Immunoglobulin—Ig) that can be detected in the...
34% of patients are asymptomatic at the time of presentation.
Anemia (73%) is the most common presentation of MM
Hypercalcemia (28%): anorexia, abdominal pain, somnolence, polydipsia, p...
Key factors to consider prior to initiation of treatment:; patient's characteristics and comorbidities (i.e. cardiac and renal function), cytogenetic risk and autologous stem cell transplant...
The survival depends heavily on the cytogenetic risk and stage of the disease.
Median survival by R-ISS stage:
Stage I: has not been...
C90.0 Multiple myeloma
C90.00 Multiple myeloma not having achieved remission
C90.01 Multiple myeloma in remission
C90.02 Multiple myeloma in relapse
109989006 Multiple myeloma
94704006 Mul...
MM is a plasma cell malignancy that causes end-organ damage.
Look for presence of “CRAB.”
Suspect MM if high total protein-to-albumin ratio is present.
Avoid nephrotoxins (radiographic co...
Sign up for a 10-day FREE Trial now and receive full access to all content.